Tema Cardiovascular and Metabolics ETF (HRTS) Price, Holdings, & News

ETF Overview

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.

Key Stats

• Today's Range: $27.33 to $27.53
• 50-Day Range: $26.25 to $30.29
• 52-Week Range: $25.32 to $36.03
• Volume: 1,932 shs
• Average Volume: 10,486 shs
• Market Capitalization: $50.83 million
• Assets Under Management: $51.09 million
• Dividend Yield: 1.72%
• Net Expense Ratio: 0.75%
• Aggregate Rating: Moderate Buy

HRTS ETF - Frequently Asked Questions

How have HRTS shares performed this year?

Tema Cardiovascular and Metabolics ETF's stock was trading at $28.87 at the start of the year. Since then, HRTS shares have decreased by 5.3% and is now trading at $27.33.
View the best growth stocks for 2025 here.

Who are Tema Cardiovascular and Metabolics ETF's major shareholders?

Tema Cardiovascular and Metabolics ETF's top institutional shareholders include Sterling Investment Advisors Ltd. (9.40%) and Flow Traders U.S. LLC (2.97%).

How do I buy shares of Tema Cardiovascular and Metabolics ETF?

Shares of HRTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Tema Cardiovascular and Metabolics ETF own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Tema Cardiovascular and Metabolics ETF investors own include Scilex (SCLX), Rigetti Computing (RGTI), Pfizer (PFE), BlackBerry (BB), Butterfly Network (BFLY), BioNTech (BNTX) and

Fund Details

• Issuer: Tema Global
• Fund Name: Tema Cardiovascular and Metabolics ETF
• Tax Classification: Regulated Investment Company
• Stock Exchange: NASDAQ
• Current Symbol: NASDAQ:HRTS
• Inception Date: 11/20/2023
• Fund Manager: David Song, Yuri Khodjamirian
• Previous Symbol: NASDAQ:HRTS
• Web: N/A
• Phone: N/A

Fund Focus

• Asset Class: Equity
• Benchmark: N/A
• Category: Strategy
• Focus: Theme
• Development Level: Blended Development
• Region: Global
• Number of Holdings: 46

Fund Statistics

• Assets Under Management: $51.09 million
• Average Daily Volume: $0.00
• Discount/Premium: -0.02%

Administrator, Advisor and Custodian

• Administrator: U.S. Bancorp Fund Services, LLC
• Advisor: Tema Global Limited
• Custodian: U.S. Bank, N.A.
• Distributor: Foreside Fund Services, LLC
• Transfer Agent: U.S. Bancorp Fund Services, LLC
• Trustee: N/A
• Lead Market Maker: Virtu Financial

Options

• Optionable: N/A
• Short Interest: 1,400 shs

Miscellaneous

• Outstanding Shares: 1,860,000
• Beta: 0.93
• Creation Unit: 10,000
• Creation Fee: $500.00